Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Revenue 2012–2025
Amphastar Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Amphastar Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 171.2 M, a 0.38% increase year-over-year.
- Amphastar Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 708.0 M, a 2.49% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. annual revenue for 2025 was 719.9 M, a 1.65% decrease from 2024.
- Amphastar Pharmaceuticals Inc. annual revenue for 2024 was 732.0 M, a 13.59% increase from 2023.
- Amphastar Pharmaceuticals Inc. annual revenue for 2023 was 644.4 M, a 29.14% increase from 2022.
- Amphastar Pharmaceuticals Inc. annual revenue for 2022 was 499.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amphastar Pharmaceuticals Inc. Revenue — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) revenue over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Amphastar Pharmaceuticals Inc.'s revenue?
Amphastar Pharmaceuticals Inc. (AMPH) reported revenue of $720M for fiscal 2025.
Where can I see AMPH's revenue history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.